If we want to accelerate scaling AI for the benefit of patients and populations, reimbursement of some form is key. Healthcare finances are complex, to say the least, so it is hard for AI creators - and for any stakeholder really - to figure out where to start. Hopefully my paper

Join me as I lead a discussion, "The Many Eyes in Artificial Intelligence” at the 2024 @PBA_SavingSight #EyeSummit! Register at: preventblindness.org/eyesummit

(autonomous) AI, medical ethics, and patient outcome. tandfonline.com/doi/full/10.10… Developing our ethical framework for medical AI led to two major contributions: a quantitative analysis of how far a given AI system - or really any healthcare process - meets multiple widely accepted

State Medicaid in Wisconsin announced they will cover Digital Diagnostics Digital Diagnostics diabetic eye exams (92229) per Jan 1, 2025. Very grateful to the Wisconsin health system users - you know who you are - who helped us advocate for this coverage; it will massively scale

Autonomous AI, like LumineticsCore Digital Diagnostics solves healthcare problems, like access and cost, at scale. But ultimately, it is all about the patient. Excited to share patient testimonials - how do patients experience having their diabetic eye exam through an autonomous AI?

Autonomous AI, like LumineticsCore Digital Diagnostics solves healthcare problems, like access and cost, at scale. But ultimately, it is all about the patient. Excited to share patient testimonials - and proud to present famous diabetes advocate Jessica Ching:

Diabetes complications are a giant public health problem in the Kingdom of Saudi Arabia, as well as many other countries in the Middle East. I am proud that Magrabi Health is using our LumineticsCore autonomous AI to help solve this problem, and I look forward to the coming

New paper in Nat Dig Med: nature.com/articles/s4174… Bias in AI, especially medical autonomous AI, is of great concern, and requires mitigation. Most will be familiar with AI bias from imbalances in the training data, or even incorrect training data. But even when such bias has

Some physicians hope to use autonomous AI diabetic eye exams to prevent visual loss in their patients with diabetes but hesitate because they worry about dilating their patient. It is great news that the American Academy of Ophthalmology is now confirming that dilating patients

here is the PR prnewswire.com/news-releases/…

On behalf of the leadership of the Collaborative Community for Ophthalmic Innovation - CCOI, I am excited to announce that Dr Malvina Eydelman, until recently Director of FDA's Office of Health Technology-1 has accepted our offer of becoming the CEO of CCOI. This is awesome

Had a lot of fun being on Maëlle Troadec 's podcast. We discussed AI deployment, ethics, and a lot more. She is a AI Policy expert at MIT and worth a follow. I hope we can still write a paper together on how we can account for policy in medical ethics. Does it operate primarily